Brunet M, van Gelder T, Åsberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, Budde K, Colom H, Dieterlen MT, Elens L, Johnson-Davis KL, Kunicki PK, MacPhee I, Masuda S, Mathew BS, Millán O, Mizuno T, Moes DAR, Monchaud C, Noceti O, Pawinski T, Picard N, van Schaik R, Sommerer C, Vethe NT, de Winter B, Christians U, Bergan S (2019) Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report. Ther Drug Monit 41(3):261–307. https://doi.org/10.1097/ftd.0000000000000640

Article  CAS  PubMed  Google Scholar 

Venkataramanan R, Jain A, Warty VS, Abu-Elmagd K, Alessiani M, Lever J, Krajak A, Flowers J, Mehta S, Zuckerman S et al (1991) Pharmacokinetics of FK 506 in transplant patients. Transplant Proc 23(6):2736–2740

CAS  PubMed  PubMed Central  Google Scholar 

Venkataramanan R, Swaminathan A, Prasad T, Jain A, Zuckerman S, Warty V, McMichael J, Lever J, Burckart G, Starzl T (1995) Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet 29(6):404–430. https://doi.org/10.2165/00003088-199529060-00003

Article  CAS  PubMed  Google Scholar 

Beringer P (2018) Winter’s basic clinical pharmacokinetics. Wolters Kluwer Health, Philadelphia, p 2018

Google Scholar 

Ette EI, Williams PJ (2004) Population pharmacokinetics I: background, concepts, and models. Ann Pharmacother 38(10):1702–1706. https://doi.org/10.1345/aph.1D374

Article  PubMed  Google Scholar 

Antignac M, Hulot JS, Boleslawski E, Hannoun L, Touitou Y, Farinotti R, Lechat P, Urien S (2005) Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearance. Eur J Clin Pharmacol 61(5–6):409–416. https://doi.org/10.1007/s00228-005-0933-6

Article  CAS  PubMed  Google Scholar 

Fukatsu S, Yano I, Igarashi T, Hashida T, Takayanagi K, Saito H, Uemoto S, Kiuchi T, Tanaka K, Inui K, Tanaka K, Inui K (2001) Population pharmacokinetics of tacrolimus in adult recipients receiving living-donor liver transplantation. Eur J Clin Pharmacol 57(6–7):479–484. https://doi.org/10.1007/s002280100331

Article  CAS  PubMed  Google Scholar 

Sam WJ, Tham LS, Holmes MJ, Aw M, Quak SH, Lee KH, Lim SG, Prabhakaran K, Chan SY, Ho PC (2006) Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients. Clin Pharmacokinet 45(1):59–75. https://doi.org/10.2165/00003088-200645010-00004

Article  CAS  PubMed  Google Scholar 

Undre NA, Schäfer A (1998) Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group. Transplant Proc 30(4):1261–1263. https://doi.org/10.1016/s0041-1345(98)00234-6

Article  CAS  PubMed  Google Scholar 

Blanchet B, Duvoux C, Costentin CE, Barrault C, Ghaleh B, Salvat A, Jouault H, Astier A, Tod M, Hulin A (2008) Pharmacokinetic-pharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early post-transplantation period. Ther Drug Monit 30(4):412–418. https://doi.org/10.1097/FTD.0b013e318178e31b

Article  CAS  PubMed  Google Scholar 

Chen B, Shi HQ, Liu XX, Zhang WX, Lu JQ, Xu BM, Chen H (2017) Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in Chinese liver transplant patients. J Clin Pharm Ther 42(6):679–688. https://doi.org/10.1111/jcpt.12599

Article  CAS  PubMed  Google Scholar 

Fukudo M, Yano I, Masuda S, Goto M, Uesugi M, Katsura T, Ogura Y, Oike F, Takada Y, Egawa H, Uemoto S, Ki I (2006) Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients. Clin Pharmacol Ther 80(4):331–345. https://doi.org/10.1016/j.clpt.2006.06.008

Article  CAS  PubMed  Google Scholar 

Li Z, Fan Q, Zhang N, Zhang C (2007) Population pharmacokinetic estimation of tacrolimus apparent clearance through multiple-linear regression. J Dalian Med Univ 29(6):535–538

CAS  Google Scholar 

Lu Y, Xu L, Cui J, Shen S, Li X (2021) Effects of postoperative day and NR1I2 on tacrolimus clearance in Chinese liver transplant recipients-a population model approach. Clin Pharmacol Drug Dev 10(11):1385–1394. https://doi.org/10.1002/cpdd.971

Article  CAS  PubMed  Google Scholar 

Lu YX, Su QH, Wu KH, Ren YP, Li L, Zhou TY, Lu W (2015) A population pharmacokinetic study of tacrolimus in healthy Chinese volunteers and liver transplant patients. Acta Pharmacol Sin 36(2):281–288. https://doi.org/10.1038/aps.2014.110

Article  CAS  PubMed  Google Scholar 

Martial LC, Biewenga M, Ruijter BN, Keizer R, Swen JJ, van Hoek B, Moes D (2021) Population pharmacokinetics and genetics of oral meltdose tacrolimus (Envarsus) in stable adult liver transplant recipients. Br J Clin Pharmacol 87(11):4262–4272. https://doi.org/10.1111/bcp.14842

Article  CAS  PubMed  Google Scholar 

Oteo I, Lukas JC, Leal N, Suarez E, Valdivieso A, Gastaca M, Ortiz de Urbina J, Calvo R (2013) Tacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian prediction. Eur J Clin Pharmacol 69(1):65–74. https://doi.org/10.1007/s00228-012-1300-z

Article  CAS  PubMed  Google Scholar 

Shao J, Wang C, Fu P, Chen F, Zhang Y, Wei J (2020) Impact of donor and recipient CYP3A5*3 genotype on tacrolimus population pharmacokinetics in Chinese adult liver transplant recipients. Ann Pharmacother 54(7):652–661. https://doi.org/10.1177/1060028019897050

Article  CAS  PubMed  Google Scholar 

Staatz CE, Willis C, Taylor PJ, Lynch SV, Tett SE (2003) Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation. Liver Transpl 9(2):130–137. https://doi.org/10.1053/jlts.2003.50023

Article  PubMed  Google Scholar 

Tharanon VSA, Intaraprasong P, Sra-ium S, Sakulchairungrueng B, Gesprasert G, Arpornsujaritkun N (2021) Population pharmacokinetics of tacrolimus in Thai liver transplant patients. Thai Bull Pharm Sci 16(1):17–30

Google Scholar 

Zhang XQ, Wang ZW, Fan JW, Li YP, Jiao Z, Gao JW, Peng ZH, Liu GL (2012) The impact of sulfonylureas on tacrolimus apparent clearance revealed by a population pharmacokinetics analysis in Chinese adult liver-transplant patients. Ther Drug Monit 34(2):126–133. https://doi.org/10.1097/FTD.0b013e31824a67eb

Article  CAS  PubMed  Google Scholar 

Zhu L, Wang H, Sun X, Rao W, Qu W, Zhang Y, Sun L (2014) The population pharmacokinetic models of tacrolimus in Chinese adult liver transplantation patients. J Pharm (Cairo) 2014:713650. https://doi.org/10.1155/2014/713650

Article  PubMed  Google Scholar 

Cai X, Li R, Sheng C, Tao Y, Zhang Q, Zhang X, Li J, Shen C, Qiu X, Wang Z, Jiao Z (2020) Systematic external evaluation of published population pharmacokinetic models for tacrolimus in adult liver transplant recipients. Eur J Pharm Sci 145:105237. https://doi.org/10.1016/j.ejps.2020.105237

Article  CAS  PubMed  Google Scholar 

Cheng Y, Wang CY, Li ZR, Pan Y, Liu MB, Jiao Z (2021) Can population pharmacokinetics of antibiotics be extrapolated? Implications of external evaluations Clin Pharmacokinet 60(1):53–68. https://doi.org/10.1007/s40262-020-00937-4

Article  CAS  PubMed  Google Scholar 

Wang DD, Chen X, Fu M, Zheng QS, Xu H, Li ZP (2020) Model extrapolation to a real-world dataset: evaluation of tacrolimus population pharmacokinetics and drug interaction in pediatric liver transplantation patients. Xenobiotica 50(4):371–379. https://doi.org/10.1080/00498254.2019.1631505

Article  CAS  PubMed  Google Scholar 

Yoon JL, Cho JJ, Park KM, Noh HM, Park YS (2015) Diagnostic performance of body mass index using the Western Pacific Regional Office of World Health Organization reference standards for body fat percentage. J Korean Med Sci 30(2):162–166. https://doi.org/10.3346/jkms.2015.30.2.162

Article  PubMed  PubMed Central  Google Scholar 

Mao JJ, Jiao Z, Yun HY, Zhao CY, Chen HC, Qiu XY, Zhong MK (2018) External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients. Br J Clin Pharmacol 84(1):153–171. https://doi.org/10.1111/bcp.13431

Article  CAS  PubMed  Google Scholar 

Zahir H, McLachlan AJ, Nelson A, McCaughan G, Gleeson M, Akhlaghi F (2005) Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients. Ther Drug Monit 27(4):422–430. https://doi.org/10.1097/01.ftd.0000170029.36573.a0

Article  CAS  PubMed  Google Scholar 

Dansirikul C, Staatz CE, Duffull SB, Taylor PJ, Lynch SV, Tett SE (2004) Sampling times for monitoring tacrolimus in stable adult liver transplant recipients. Ther Drug Monit 26(6):593–599. https://doi.org/10.1097/00007691-200412000-00003

Article  CAS  PubMed  Google Scholar 

Kourkoumpetis T, Levitsky J (2019) Immunosuppressive drug levels in liver transplant recipients: Impact in decision making. Semin Liver Dis 39(4):414–421. https://doi.org/10.1055/s-0039-1688443

Article  CAS  PubMed  Google Scholar 

Karlsson MO, Savic RM (2007) Diagnosing model diagnostics. Clin Pharmacol Ther 82(1):17–20. https://doi.org/10.1038/sj.clpt.6100241

Article  CAS  PubMed  Google Scholar 

Mould DR, D’Haens G, Upton RN (2016) Clinical decision support tools: the evolution of a revolution. Clin Pharmacol Ther 99(4):405–418. https://doi.org/10.1002/cpt.334

Article  CAS  PubMed  Google Scholar 

Guo T, van Hest RM, Zwep LB, Roggeveen LF, Fleuren LM, Bosman RJ, van der Voort PHJ, Girbes ARJ, Mathot RAA, Elbers PWG, van Hasselt JGC (2020) Optimizing predictive performance of Bayesian forecasting for vancomycin concentration in intensive care patients. Pharm Res 37(9):171. https://doi.org/10.1007/s11095-020-02908-7